instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Cerebral aspergillosis'? | Invasive Fungal Infection Complicating Treatment With Ibrutinib.
Ibrutinib is a selective Bruton's tyrosine kinase inhibitor (BTKi) approved for the treatment of chronic lymphocytic leukemia (CLL) and other B-cell malignancies. Invasive fungal infections (IFIs) have recently been reported in patients on BTKis despite t... | Fatal | ReactionOutcome | CC BY | 34336499 | 19,718,771 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | A case of remarkable response to atezolizumab in ALK-translocated metastatic lung adenocarcinoma.
The development of resistance to tyrosine kinase inhibitors (TKIs) in metastatic non-small cell lung cancer (NSCLC) with oncogenic driver mutations highlights the challenge in improving the survival of these patients. The ... | ATEZOLIZUMAB, BEVACIZUMAB, CARBOPLATIN, PEMETREXED | DrugsGivenReaction | CC BY-NC-ND | 34336591 | 20,624,717 | 2021 |
What was the dosage of drug 'ATEZOLIZUMAB'? | A case of remarkable response to atezolizumab in ALK-translocated metastatic lung adenocarcinoma.
The development of resistance to tyrosine kinase inhibitors (TKIs) in metastatic non-small cell lung cancer (NSCLC) with oncogenic driver mutations highlights the challenge in improving the survival of these patients. The ... | 1200 MILLIGRAM, EVERY 3 WEEKS | DrugDosageText | CC BY-NC-ND | 34336591 | 20,624,717 | 2021 |
What was the dosage of drug 'BEVACIZUMAB'? | A case of remarkable response to atezolizumab in ALK-translocated metastatic lung adenocarcinoma.
The development of resistance to tyrosine kinase inhibitors (TKIs) in metastatic non-small cell lung cancer (NSCLC) with oncogenic driver mutations highlights the challenge in improving the survival of these patients. The ... | 7.5 MILLIGRAM/KILOGRAM, EVERY 3 WEEKS | DrugDosageText | CC BY-NC-ND | 34336591 | 20,624,717 | 2021 |
What was the dosage of drug 'CARBOPLATIN'? | A case of remarkable response to atezolizumab in ALK-translocated metastatic lung adenocarcinoma.
The development of resistance to tyrosine kinase inhibitors (TKIs) in metastatic non-small cell lung cancer (NSCLC) with oncogenic driver mutations highlights the challenge in improving the survival of these patients. The ... | AUC 5, EVERY 3 WEEKS | DrugDosageText | CC BY-NC-ND | 34336591 | 20,624,717 | 2021 |
What was the dosage of drug 'PEMETREXED'? | A case of remarkable response to atezolizumab in ALK-translocated metastatic lung adenocarcinoma.
The development of resistance to tyrosine kinase inhibitors (TKIs) in metastatic non-small cell lung cancer (NSCLC) with oncogenic driver mutations highlights the challenge in improving the survival of these patients. The ... | 500 MILLIGRAM/SQ. METER, EVERY 3 WEEKS | DrugDosageText | CC BY-NC-ND | 34336591 | 20,624,717 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ageusia'. | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | ALLOPURINOL, AZITHROMYCIN, HYALURONIC ACID, HYDROCHLOROTHIAZIDE, HYDROXYCHLOROQUINE, OLMESARTAN, PREDNISONE, SALMETEROL, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY-NC-ND | 34337095 | 20,390,911 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anosmia'. | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | ALLOPURINOL, AZITHROMYCIN, HYALURONIC ACID, HYDROCHLOROTHIAZIDE, HYDROXYCHLOROQUINE, OLMESARTAN, PREDNISONE, SALMETEROL, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY-NC-ND | 34337095 | 20,390,911 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chills'. | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | ALLOPURINOL, AZITHROMYCIN, HYALURONIC ACID, HYDROCHLOROTHIAZIDE, HYDROXYCHLOROQUINE, OLMESARTAN, PREDNISONE, SALMETEROL, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY-NC-ND | 34337095 | 20,390,911 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cough'. | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | ALLOPURINOL, AZITHROMYCIN, HYALURONIC ACID, HYDROCHLOROTHIAZIDE, HYDROXYCHLOROQUINE, OLMESARTAN, PREDNISONE, SALMETEROL, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY-NC-ND | 34337095 | 20,390,911 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyspnoea'. | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | ALLOPURINOL, AZITHROMYCIN, HYALURONIC ACID, HYDROCHLOROTHIAZIDE, HYDROXYCHLOROQUINE, OLMESARTAN, PREDNISONE, SALMETEROL, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY-NC-ND | 34337095 | 20,390,911 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Legionella infection'. | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | ALLOPURINOL, AMOXICILLIN\CLAVULANIC ACID, AZITHROMYCIN, DEXAMETHASONE, ENOXAPARIN, HYALURONIC ACID, HYDROCHLOROTHIAZIDE, HYDROXYCHLOROQUINE, OLMESARTAN, PREDNISONE, REMDESIVIR, SALMETEROL, TOCILIZUMAB, TRIAMCINOLONE | DrugsGivenReaction | CC BY-NC-ND | 34337095 | 20,154,067 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myalgia'. | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | ALLOPURINOL, AZITHROMYCIN, HYALURONIC ACID, HYDROCHLOROTHIAZIDE, HYDROXYCHLOROQUINE, OLMESARTAN, PREDNISONE, SALMETEROL, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY-NC-ND | 34337095 | 20,390,911 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumococcal infection'. | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | ALLOPURINOL, AMOXICILLIN\CLAVULANIC ACID, AZITHROMYCIN, DEXAMETHASONE, ENOXAPARIN, HYALURONIC ACID, HYDROCHLOROTHIAZIDE, HYDROXYCHLOROQUINE, OLMESARTAN, PREDNISONE, REMDESIVIR, SALMETEROL, TOCILIZUMAB, TRIAMCINOLONE | DrugsGivenReaction | CC BY-NC-ND | 34337095 | 20,154,067 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | ALLOPURINOL, AZITHROMYCIN, HYALURONIC ACID, HYDROCHLOROTHIAZIDE, HYDROXYCHLOROQUINE, OLMESARTAN, PREDNISONE, SALMETEROL, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY-NC-ND | 34337095 | 20,390,911 | 2021-07 |
What is the weight of the patient? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | 92 kg. | Weight | CC BY-NC-ND | 34337095 | 20,045,374 | 2021-07 |
What was the administration route of drug 'AMOXICILLIN\CLAVULANATE POTASSIUM'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34337095 | 20,158,739 | 2021-07 |
What was the administration route of drug 'AMOXICILLIN\CLAVULANIC ACID'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34337095 | 20,154,067 | 2021-07 |
What was the administration route of drug 'AZITHROMYCIN'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34337095 | 20,154,067 | 2021-07 |
What was the administration route of drug 'DEXAMETHASONE'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34337095 | 20,154,067 | 2021-07 |
What was the administration route of drug 'ENOXAPARIN SODIUM'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 34337095 | 20,158,739 | 2021-07 |
What was the administration route of drug 'ENOXAPARIN'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 34337095 | 20,154,067 | 2021-07 |
What was the administration route of drug 'HYALURONIC ACID'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Intra-articular | DrugAdministrationRoute | CC BY-NC-ND | 34337095 | 20,045,374 | 2021-07 |
What was the administration route of drug 'HYDROXYCHLOROQUINE SULFATE'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34337095 | 20,045,374 | 2021-07 |
What was the administration route of drug 'HYDROXYCHLOROQUINE'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34337095 | 20,154,067 | 2021-07 |
What was the administration route of drug 'PREDNISOLONE'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34337095 | 20,143,089 | 2021-07 |
What was the administration route of drug 'PREDNISONE'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34337095 | 20,045,374 | 2021-07 |
What was the administration route of drug 'SALMETEROL'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Respiratory (inhalation) | DrugAdministrationRoute | CC BY-NC-ND | 34337095 | 20,166,446 | 2021-07 |
What was the administration route of drug 'TOCILIZUMAB'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34337095 | 20,154,067 | 2021-07 |
What was the administration route of drug 'TRIAMCINOLONE ACETONIDE'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Intra-articular | DrugAdministrationRoute | CC BY-NC-ND | 34337095 | 20,045,374 | 2021-07 |
What was the administration route of drug 'TRIAMCINOLONE'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Intra-articular | DrugAdministrationRoute | CC BY-NC-ND | 34337095 | 20,154,067 | 2021-07 |
What was the dosage of drug 'SALMETEROL'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | UNK, INHALED | DrugDosageText | CC BY-NC-ND | 34337095 | 20,158,739 | 2021-07 |
What was the outcome of reaction 'Acute respiratory distress syndrome'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Recovered | ReactionOutcome | CC BY-NC-ND | 34337095 | 20,045,374 | 2021-07 |
What was the outcome of reaction 'Ageusia'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Recovered | ReactionOutcome | CC BY-NC-ND | 34337095 | 20,390,911 | 2021-07 |
What was the outcome of reaction 'Anosmia'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Recovered | ReactionOutcome | CC BY-NC-ND | 34337095 | 20,390,911 | 2021-07 |
What was the outcome of reaction 'COVID-19'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Recovered | ReactionOutcome | CC BY-NC-ND | 34337095 | 20,045,374 | 2021-07 |
What was the outcome of reaction 'Chills'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Recovered | ReactionOutcome | CC BY-NC-ND | 34337095 | 20,390,911 | 2021-07 |
What was the outcome of reaction 'Condition aggravated'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Recovered | ReactionOutcome | CC BY-NC-ND | 34337095 | 20,042,509 | 2021-07 |
What was the outcome of reaction 'Cough'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Recovered | ReactionOutcome | CC BY-NC-ND | 34337095 | 20,390,911 | 2021-07 |
What was the outcome of reaction 'Dyspnoea'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Recovered | ReactionOutcome | CC BY-NC-ND | 34337095 | 20,390,911 | 2021-07 |
What was the outcome of reaction 'Legionella infection'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Recovered | ReactionOutcome | CC BY-NC-ND | 34337095 | 20,154,067 | 2021-07 |
What was the outcome of reaction 'Lymphopenia'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Recovered | ReactionOutcome | CC BY-NC-ND | 34337095 | 20,045,374 | 2021-07 |
What was the outcome of reaction 'Myalgia'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Recovered | ReactionOutcome | CC BY-NC-ND | 34337095 | 20,390,911 | 2021-07 |
What was the outcome of reaction 'Pneumococcal infection'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Recovered | ReactionOutcome | CC BY-NC-ND | 34337095 | 20,154,067 | 2021-07 |
What was the outcome of reaction 'Pneumonia'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Recovered | ReactionOutcome | CC BY-NC-ND | 34337095 | 20,045,374 | 2021-07 |
What was the outcome of reaction 'Pyrexia'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Recovered | ReactionOutcome | CC BY-NC-ND | 34337095 | 20,390,911 | 2021-07 |
What was the outcome of reaction 'Respiratory failure'? | Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections have been reported; however, most cases are milder than the primary infection. We report the first case of a life-threatening critical presenta... | Recovered | ReactionOutcome | CC BY-NC-ND | 34337095 | 20,045,374 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Alternative Management of a Pediatric Case of Hemorrhagic Cystitis due to BK Virus: Use of Thulium Laser Coagulation.
We report on a pediatric case of hemorrhagic cystitis due to BK virus in a patient with acute lymphoblastic leukemia who had undergone bone marrow transplantation. A very large hematoma that almost comp... | CYCLOSPORINE, FILGRASTIM, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 34337516 | 19,593,223 | 2021-05 |
What was the administration route of drug 'CYCLOSPORINE'? | Alternative Management of a Pediatric Case of Hemorrhagic Cystitis due to BK Virus: Use of Thulium Laser Coagulation.
We report on a pediatric case of hemorrhagic cystitis due to BK virus in a patient with acute lymphoblastic leukemia who had undergone bone marrow transplantation. A very large hematoma that almost comp... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34337516 | 19,647,617 | 2021-05 |
What was the administration route of drug 'DEXAMETHASONE'? | Alternative Management of a Pediatric Case of Hemorrhagic Cystitis due to BK Virus: Use of Thulium Laser Coagulation.
We report on a pediatric case of hemorrhagic cystitis due to BK virus in a patient with acute lymphoblastic leukemia who had undergone bone marrow transplantation. A very large hematoma that almost comp... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34337516 | 19,647,617 | 2021-05 |
What was the administration route of drug 'EQUINE THYMOCYTE IMMUNE GLOBULIN'? | Alternative Management of a Pediatric Case of Hemorrhagic Cystitis due to BK Virus: Use of Thulium Laser Coagulation.
We report on a pediatric case of hemorrhagic cystitis due to BK virus in a patient with acute lymphoblastic leukemia who had undergone bone marrow transplantation. A very large hematoma that almost comp... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34337516 | 19,591,062 | 2021-05 |
What was the administration route of drug 'FILGRASTIM'? | Alternative Management of a Pediatric Case of Hemorrhagic Cystitis due to BK Virus: Use of Thulium Laser Coagulation.
We report on a pediatric case of hemorrhagic cystitis due to BK virus in a patient with acute lymphoblastic leukemia who had undergone bone marrow transplantation. A very large hematoma that almost comp... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34337516 | 19,647,617 | 2021-05 |
What was the administration route of drug 'MYCOPHENOLATE MOFETIL'? | Alternative Management of a Pediatric Case of Hemorrhagic Cystitis due to BK Virus: Use of Thulium Laser Coagulation.
We report on a pediatric case of hemorrhagic cystitis due to BK virus in a patient with acute lymphoblastic leukemia who had undergone bone marrow transplantation. A very large hematoma that almost comp... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34337516 | 19,591,062 | 2021-05 |
What was the administration route of drug 'THYMOCYTE IMMUNE GLOBULIN NOS'? | Alternative Management of a Pediatric Case of Hemorrhagic Cystitis due to BK Virus: Use of Thulium Laser Coagulation.
We report on a pediatric case of hemorrhagic cystitis due to BK virus in a patient with acute lymphoblastic leukemia who had undergone bone marrow transplantation. A very large hematoma that almost comp... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34337516 | 19,647,617 | 2021-05 |
What was the dosage of drug 'ETOPOSIDE'? | Alternative Management of a Pediatric Case of Hemorrhagic Cystitis due to BK Virus: Use of Thulium Laser Coagulation.
We report on a pediatric case of hemorrhagic cystitis due to BK virus in a patient with acute lymphoblastic leukemia who had undergone bone marrow transplantation. A very large hematoma that almost comp... | STARTING FROM PRE?TRANSPLANTATION PERIOD | DrugDosageText | CC BY-NC-ND | 34337516 | 19,647,617 | 2021-05 |
What was the outcome of reaction 'Cystitis haemorrhagic'? | Alternative Management of a Pediatric Case of Hemorrhagic Cystitis due to BK Virus: Use of Thulium Laser Coagulation.
We report on a pediatric case of hemorrhagic cystitis due to BK virus in a patient with acute lymphoblastic leukemia who had undergone bone marrow transplantation. A very large hematoma that almost comp... | Recovered | ReactionOutcome | CC BY-NC-ND | 34337516 | 19,603,628 | 2021-05 |
What was the outcome of reaction 'Haematuria'? | Alternative Management of a Pediatric Case of Hemorrhagic Cystitis due to BK Virus: Use of Thulium Laser Coagulation.
We report on a pediatric case of hemorrhagic cystitis due to BK virus in a patient with acute lymphoblastic leukemia who had undergone bone marrow transplantation. A very large hematoma that almost comp... | Recovered | ReactionOutcome | CC BY-NC-ND | 34337516 | 19,603,628 | 2021-05 |
What was the outcome of reaction 'Urinary bladder haematoma'? | Alternative Management of a Pediatric Case of Hemorrhagic Cystitis due to BK Virus: Use of Thulium Laser Coagulation.
We report on a pediatric case of hemorrhagic cystitis due to BK virus in a patient with acute lymphoblastic leukemia who had undergone bone marrow transplantation. A very large hematoma that almost comp... | Recovered | ReactionOutcome | CC BY-NC-ND | 34337516 | 19,647,617 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Scurvy as an Alarm Bell of Autistic Spectrum Disorder in the First World: A Case Report of a 3-Year-Old Girl.
BACKGROUND Scurvy secondary to deficiency of vitamin C is a rare condition in children. The polymorphism of clinical signs and symptoms makes scurvy diagnosis a challenge for the pediatrician. CASE REPORT A 3-y... | IBUPROFEN | DrugsGivenReaction | CC BY-NC-ND | 34339404 | 20,643,545 | 2021-08-02 |
What is the weight of the patient? | Scurvy as an Alarm Bell of Autistic Spectrum Disorder in the First World: A Case Report of a 3-Year-Old Girl.
BACKGROUND Scurvy secondary to deficiency of vitamin C is a rare condition in children. The polymorphism of clinical signs and symptoms makes scurvy diagnosis a challenge for the pediatrician. CASE REPORT A 3-y... | 12 kg. | Weight | CC BY-NC-ND | 34339404 | 20,643,545 | 2021-08-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Resistance patterns and clinical outcomes of Klebsiella pneumoniae and invasive Klebsiella variicola in trauma patients.
Recent reclassification of the Klebsiella genus to include Klebsiella variicola, and its association with bacteremia and mortality, has raised concerns. We examined Klebsiella spp. infections among b... | CEFAZOLIN, ERTAPENEM, GENTAMICIN, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM | DrugsGivenReaction | CC0 | 34339473 | 20,458,109 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | APIXABAN, AZOSEMIDE, CANDESARTAN, FUROSEMIDE, HEPARIN SODIUM, LINEZOLID, MEROPENEM, MICAFUNGIN, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, TEICOPLANIN, TOLVAPTAN, TRAFERMIN, VANCOMYCIN | DrugsGivenReaction | CC BY | 34340688 | 20,505,722 | 2021-08-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | APIXABAN, AZOSEMIDE, CANDESARTAN, FUROSEMIDE, HEPARIN SODIUM, LINEZOLID, MEROPENEM, MICAFUNGIN, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, TEICOPLANIN, TOLVAPTAN, TRAFERMIN, VANCOMYCIN | DrugsGivenReaction | CC BY | 34340688 | 20,505,722 | 2021-08-03 |
What was the administration route of drug 'AZOSEMIDE'? | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | Oral | DrugAdministrationRoute | CC BY | 34340688 | 20,505,722 | 2021-08-03 |
What was the administration route of drug 'FUROSEMIDE'? | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | Oral | DrugAdministrationRoute | CC BY | 34340688 | 20,505,722 | 2021-08-03 |
What was the administration route of drug 'LINEZOLID'? | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | Oral | DrugAdministrationRoute | CC BY | 34340688 | 20,505,722 | 2021-08-03 |
What was the administration route of drug 'MEROPENEM'? | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34340688 | 20,383,232 | 2021-08-03 |
What was the administration route of drug 'MICAFUNGIN'? | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34340688 | 20,383,232 | 2021-08-03 |
What was the administration route of drug 'PIPERACILLIN SODIUM\TAZOBACTAM SODIUM'? | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34340688 | 20,505,722 | 2021-08-03 |
What was the administration route of drug 'TEICOPLANIN'? | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34340688 | 20,505,722 | 2021-08-03 |
What was the administration route of drug 'TOLVAPTAN'? | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | Oral | DrugAdministrationRoute | CC BY | 34340688 | 20,505,722 | 2021-08-03 |
What was the administration route of drug 'TRAFERMIN'? | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | Topical | DrugAdministrationRoute | CC BY | 34340688 | 20,505,722 | 2021-08-03 |
What was the administration route of drug 'VANCOMYCIN HYDROCHLORIDE'? | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34340688 | 20,490,201 | 2021-08-03 |
What was the administration route of drug 'VANCOMYCIN'? | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34340688 | 20,505,722 | 2021-08-03 |
What was the dosage of drug 'CANDESARTAN'? | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | 8 MG | DrugDosageText | CC BY | 34340688 | 20,505,722 | 2021-08-03 |
What was the dosage of drug 'PIPERACILLIN SODIUM\TAZOBACTAM SODIUM'? | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | 4.5 GRAM, TID | DrugDosageText | CC BY | 34340688 | 20,505,722 | 2021-08-03 |
What was the dosage of drug 'TEICOPLANIN'? | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | 400 MG, EVERY 48 HOURS | DrugDosageText | CC BY | 34340688 | 20,505,722 | 2021-08-03 |
What was the dosage of drug 'VANCOMYCIN HYDROCHLORIDE'? | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | 0.5 GRAM, EVERY 12 HOURS | DrugDosageText | CC BY | 34340688 | 20,490,201 | 2021-08-03 |
What was the dosage of drug 'VANCOMYCIN'? | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | 0.5 GRAM, BID | DrugDosageText | CC BY | 34340688 | 20,505,722 | 2021-08-03 |
What was the outcome of reaction 'Drug ineffective for unapproved indication'? | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | Fatal | ReactionOutcome | CC BY | 34340688 | 20,505,722 | 2021-08-03 |
What was the outcome of reaction 'Drug ineffective'? | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | Fatal | ReactionOutcome | CC BY | 34340688 | 20,383,232 | 2021-08-03 |
What was the outcome of reaction 'Sepsis'? | Polycystic liver disease with lethal abdominal wall rupture: a case report.
BACKGROUND
Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney. Dialysis therapy can be used for renal failure, but liver t... | Fatal | ReactionOutcome | CC BY | 34340688 | 20,383,232 | 2021-08-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Neutropaenic enterocolitis: A medical/surgical oncological dilemma.
Neutropaenic enterocolitis (NE) is a life-threatening condition characterised by an inflammation of the colon and/or the small bowel in the background of chemotherapy-induced neutropaenia. A 16-year-old girl with acute myeloblastic leukaemia (AML) deve... | CYCLOPHOSPHAMIDE, CYTARABINE, PREDNISOLONE, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY-NC-SA | 34341204 | 19,979,844 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Appendicitis'. | Neutropaenic enterocolitis: A medical/surgical oncological dilemma.
Neutropaenic enterocolitis (NE) is a life-threatening condition characterised by an inflammation of the colon and/or the small bowel in the background of chemotherapy-induced neutropaenia. A 16-year-old girl with acute myeloblastic leukaemia (AML) deve... | CYCLOPHOSPHAMIDE, CYTARABINE, PREDNISOLONE, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY-NC-SA | 34341204 | 19,979,844 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Neutropaenic enterocolitis: A medical/surgical oncological dilemma.
Neutropaenic enterocolitis (NE) is a life-threatening condition characterised by an inflammation of the colon and/or the small bowel in the background of chemotherapy-induced neutropaenia. A 16-year-old girl with acute myeloblastic leukaemia (AML) deve... | CYCLOPHOSPHAMIDE, CYTARABINE, PREDNISOLONE, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY-NC-SA | 34341204 | 19,979,844 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Neutropaenic enterocolitis: A medical/surgical oncological dilemma.
Neutropaenic enterocolitis (NE) is a life-threatening condition characterised by an inflammation of the colon and/or the small bowel in the background of chemotherapy-induced neutropaenia. A 16-year-old girl with acute myeloblastic leukaemia (AML) deve... | CYCLOPHOSPHAMIDE, CYTARABINE, PREDNISOLONE, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY-NC-SA | 34341204 | 19,979,844 | 2021 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Neutropaenic enterocolitis: A medical/surgical oncological dilemma.
Neutropaenic enterocolitis (NE) is a life-threatening condition characterised by an inflammation of the colon and/or the small bowel in the background of chemotherapy-induced neutropaenia. A 16-year-old girl with acute myeloblastic leukaemia (AML) deve... | UNK, INDUCTION CHEMOTHERAPY | DrugDosageText | CC BY-NC-SA | 34341204 | 19,979,844 | 2021 |
What was the dosage of drug 'CYTARABINE'? | Neutropaenic enterocolitis: A medical/surgical oncological dilemma.
Neutropaenic enterocolitis (NE) is a life-threatening condition characterised by an inflammation of the colon and/or the small bowel in the background of chemotherapy-induced neutropaenia. A 16-year-old girl with acute myeloblastic leukaemia (AML) deve... | UNK, INDUCTION CHEMOTHERAPY | DrugDosageText | CC BY-NC-SA | 34341204 | 19,979,844 | 2021 |
What was the dosage of drug 'PREDNISOLONE'? | Neutropaenic enterocolitis: A medical/surgical oncological dilemma.
Neutropaenic enterocolitis (NE) is a life-threatening condition characterised by an inflammation of the colon and/or the small bowel in the background of chemotherapy-induced neutropaenia. A 16-year-old girl with acute myeloblastic leukaemia (AML) deve... | UNK, INDUCTION CHEMOTHERAPY | DrugDosageText | CC BY-NC-SA | 34341204 | 19,979,844 | 2021 |
What was the dosage of drug 'VINCRISTINE SULFATE'? | Neutropaenic enterocolitis: A medical/surgical oncological dilemma.
Neutropaenic enterocolitis (NE) is a life-threatening condition characterised by an inflammation of the colon and/or the small bowel in the background of chemotherapy-induced neutropaenia. A 16-year-old girl with acute myeloblastic leukaemia (AML) deve... | UNK, INDUCTION CHEMOTHERAPY | DrugDosageText | CC BY-NC-SA | 34341204 | 19,979,844 | 2021 |
What was the outcome of reaction 'Appendicitis'? | Neutropaenic enterocolitis: A medical/surgical oncological dilemma.
Neutropaenic enterocolitis (NE) is a life-threatening condition characterised by an inflammation of the colon and/or the small bowel in the background of chemotherapy-induced neutropaenia. A 16-year-old girl with acute myeloblastic leukaemia (AML) deve... | Recovered | ReactionOutcome | CC BY-NC-SA | 34341204 | 19,979,844 | 2021 |
What was the outcome of reaction 'Neutropenic colitis'? | Neutropaenic enterocolitis: A medical/surgical oncological dilemma.
Neutropaenic enterocolitis (NE) is a life-threatening condition characterised by an inflammation of the colon and/or the small bowel in the background of chemotherapy-induced neutropaenia. A 16-year-old girl with acute myeloblastic leukaemia (AML) deve... | Recovered | ReactionOutcome | CC BY-NC-SA | 34341204 | 20,003,401 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lactic acidosis'. | An Atypical Presentation of Hemophagocytic Lymphohistiocytosis (HLH) Secondary to Occult Hodgkin Lymphoma.
Hemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening syndrome of immune system dysregulation characterized by the phagocytosis of various cells by histiocytes in the bone marrow. HLH can present... | BRENTUXIMAB VEDOTIN, DEXAMETHASONE, ETOPOSIDE | DrugsGivenReaction | CC BY | 34341690 | 19,972,753 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal failure'. | An Atypical Presentation of Hemophagocytic Lymphohistiocytosis (HLH) Secondary to Occult Hodgkin Lymphoma.
Hemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening syndrome of immune system dysregulation characterized by the phagocytosis of various cells by histiocytes in the bone marrow. HLH can present... | BRENTUXIMAB VEDOTIN, DEXAMETHASONE, ETOPOSIDE | DrugsGivenReaction | CC BY | 34341690 | 19,972,753 | 2021 |
What was the dosage of drug 'BRENTUXIMAB VEDOTIN'? | An Atypical Presentation of Hemophagocytic Lymphohistiocytosis (HLH) Secondary to Occult Hodgkin Lymphoma.
Hemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening syndrome of immune system dysregulation characterized by the phagocytosis of various cells by histiocytes in the bone marrow. HLH can present... | 1.8 MG/KG, SINGLE | DrugDosageText | CC BY | 34341690 | 19,972,753 | 2021 |
What was the dosage of drug 'DEXAMETHASONE'? | An Atypical Presentation of Hemophagocytic Lymphohistiocytosis (HLH) Secondary to Occult Hodgkin Lymphoma.
Hemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening syndrome of immune system dysregulation characterized by the phagocytosis of various cells by histiocytes in the bone marrow. HLH can present... | 20 MG, QD | DrugDosageText | CC BY | 34341690 | 19,972,753 | 2021 |
What was the dosage of drug 'ETOPOSIDE'? | An Atypical Presentation of Hemophagocytic Lymphohistiocytosis (HLH) Secondary to Occult Hodgkin Lymphoma.
Hemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening syndrome of immune system dysregulation characterized by the phagocytosis of various cells by histiocytes in the bone marrow. HLH can present... | 100 MG/ML, 2/WEEK | DrugDosageText | CC BY | 34341690 | 19,972,753 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal disorder'. | The Effectiveness of Lapatinib in HER2-Positive Metastatic Breast Cancer Patients Pretreated With Multiline Anti-HER2 Treatment: A Retrospective Study in China.
The aim of this study was to evaluate the effectiveness of lapatinib in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer.
W... | CAPECITABINE, LAPATINIB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC | 34342244 | 19,784,459 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nervous system disorder'. | The Effectiveness of Lapatinib in HER2-Positive Metastatic Breast Cancer Patients Pretreated With Multiline Anti-HER2 Treatment: A Retrospective Study in China.
The aim of this study was to evaluate the effectiveness of lapatinib in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer.
W... | CAPECITABINE, LAPATINIB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC | 34342244 | 19,784,459 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | The Effectiveness of Lapatinib in HER2-Positive Metastatic Breast Cancer Patients Pretreated With Multiline Anti-HER2 Treatment: A Retrospective Study in China.
The aim of this study was to evaluate the effectiveness of lapatinib in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer.
W... | CAPECITABINE, LAPATINIB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC | 34342244 | 19,784,459 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.